SWS Hemodialysis Care Co (SHSE:688410) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688410 SWS Hemodialysis Care Co Ltd SHSE:688410
84 GF Score
Price ¥9.97
GF Value ¥15.73
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is SWS Hemodialysis Care Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SWS Hemodialysis Care Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ¥54.1 Mil. SWS Hemodialysis Care Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ¥0.9 Mil. SWS Hemodialysis Care Co's annualized EBITDA for the quarter that ended in Jun. 2026 was ¥196.8 Mil. SWS Hemodialysis Care Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 0.28.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SWS Hemodialysis Care Co's Debt-to-EBITDA or its related term are showing as below:

SHSE:688410' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -31.04   Med: 0.03   Max: 3.2
Current: 0.01

During the past 7 years, the highest Debt-to-EBITDA Ratio of SWS Hemodialysis Care Co was 3.20. The lowest was -31.04. And the median was 0.03.

SHSE:688410's Debt-to-EBITDA is ranked better than
99.79% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 1.64 vs SHSE:688410: 0.01

SWS Hemodialysis Care Co  (SHSE:688410) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


SWS Hemodialysis Care Co Debt-to-EBITDA Related Terms


SWS Hemodialysis Care Co Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for SWS Hemodialysis Care Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SWS Hemodialysis Care Co Debt-to-EBITDA Chart

SWS Hemodialysis Care Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial - - - - -

SWS Hemodialysis Care Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SHSE:688410 vs ISRG, BDX, RMD: Debt-to-EBITDA Comparison

For the Medical Devices subindustry, SWS Hemodialysis Care Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SWS Hemodialysis Care Co Debt-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SWS Hemodialysis Care Co's Debt-to-EBITDA falls into.


SHSE:688410
84GF Score
SWS Hemodialysis Care Co Ltd SHSE:688410
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SWS Hemodialysis Care Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SWS Hemodialysis Care Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(63.95380912 + 0.73263038) / 188.39503962
=0.34

SWS Hemodialysis Care Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(54.0735763 + 0.86860867) / 196.78075246
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?

Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued. The current stock price of ¥9.97 is trading 36.6% below its estimated GF Value™ of ¥15.73. GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.

Key valuation signals for SHSE:688410:

  • Debt-to-EBITDA:
  • GF Value™: ¥15.73 vs. price of ¥9.97 (36.6% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SWS Hemodialysis Care Co Business Description

Address No. 1, Ciji Road, Liangjiang New District, Chongqing, CHN, 401123
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
84GF Score

Get the complete analysis for SHSE:688410

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.97
Price
¥15.73
GF Value